3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
8
Unknown
7
Not yet recruiting
4
Recruiting
2
Enrolling by invitation
2
Terminated
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
705
Carcinoma, Non-Small-Cell Lung
472
Prostatic Neoplasms
420
Neoplasms
379
Multiple Myeloma
261
Colorectal Neoplasms
261
Lung Neoplasms
248
Neoplasm Metastasis
230
Melanoma
215
Ovarian Neoplasms
191
Leukemia, Myeloid, Acute
190
Pancreatic Neoplasms
181
Squamous Cell Carcinoma of Head and Neck
163
Recurrence
146
Carcinoma, Renal Cell
144
Lymphoma
142
Glioblastoma
138
Lymphoma, Non-Hodgkin
134
Stomach Neoplasms
129
Triple Negative Breast Neoplasms
127
Carcinoma, Hepatocellular
123
Brain Neoplasms
123
Leukemia, Lymphocytic, Chronic, B-Cell
122
Uterine Cervical Neoplasms
117
Head and Neck Neoplasms
117
Precursor Cell Lymphoblastic Leukemia-Lymphoma
115
Urinary Bladder Neoplasms
113
Lymphoma, Large B-Cell, Diffuse
105
Sarcoma
102
Lymphoma, Follicular
100
Interventions
Palliative Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Interventional
×
Chemotherapy-Related Cognitive Impairment
×
Clear all
NCT04586530
2026-01-21
TAMS
University of Pittsburgh
Phase NA
Active not recruiting
220 enrolled